Adam Gazzaley, MD, PhD
Director, Neuroscience Imaging Center
Dr. Adam Gazzaley obtained his medical and doctorate degrees in Neuroscience at the Mount Sinai School of Medicine in New York, completed clinical residency in Neurology at the University of Pennsylvania, and postdoctoral training in cognitive neuroscience at UC Berkeley. He is now Professor in Neurology, Physiology and Psychiatry at the UC San Francisco, the founding director of the Neuroscience Imaging Center, and director of the Gazzaley Lab, a cognitive neuroscience laboratory. His laboratory studies neural mechanisms of perception, attention and memory, with an emphasis on the impact of distraction and multitasking on these abilities. His unique research approach utilizes a powerful combination of human neurophysiological tools, including functional magnetic resonance imaging (fMRI), electroencephalography (EEG) and transcranial magnetic and electrical stimulation (TMS & TES). A major accomplishment of his research has been to expand our understanding of alterations in the aging brain that lead to cognitive decline. His most recent studies explore how we can enhance our cognitive abilities via engagement with custom-designed video games, and how this can be bolstered by closed loop systems using neurofeedback and TES. Dr. Gazzaley is the founder and chief science advisor of Akili Interactive Labs, a company developing the first therapeutic video games. He also advises a dozen companies in the technology domain, including GE and Nielsen. Dr. Gazzaley has filed multiple patents based in his research, authored over 100 scientific articles, and delivered over 400 invited presentations around the world. His research and perspectives have been consistently profiled in high-impact media, such as The New York Times, New York Times Magazine, New Yorker, Wall Street Journal, TIME, Discover, Wired, PBS, NPR, CNN and NBC Nightly News. He wrote and hosted the nationally televised, PBS special “The Distracted Mind with Dr. Adam Gazzaley”. National Awards and honors for his research include the Pfizer/AFAR Innovations in Aging Award, the Ellison Foundation New Scholar Award in Aging, and the Harold Brenner Pepinsky Early Career Award in Neurobehavioral Science.